Hematology & Oncology Doctors in Cambridge, MA Accepting Medicare

8 Hematology & Oncology doctors found. Showing 1 - 8

Dr. Thomas Caughey, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 300 Mount Auburn St, Hema/onc, Cambridge, MA 02138 Phone: 617-497-9646    Fax: 617-499-5464

Charles D Taylor, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-1552    Fax: 617-665-1925

Debashish Misra, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-1552

David S. Rosenthal, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 75 Mount Auburn St, Harvard University Health Services, Cambridge, MA 02138 Phone: 617-495-2010    Fax: 617-495-8078

Dr. Matthew Robert Kaufman, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 330 Mount Auburn St, Cambridge, MA 02138 Phone: 617-497-9646    Fax: 617-499-5464

Iris Yeong- Fung Sheng, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 100 Mount Auburn St, Cambridge, MA 02138 Phone: 617-497-9646

Robert J Fram, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: Immunogen, Inc., 128 Sidney St, Cambridge, MA 02138 Phone: 617-995-4909

Anna Berkenblit, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 35 Cambridge Park Dr., Cambridge, MA 02140 Phone: 617-665-7796

News Archive

ADA Seal of Acceptance helps consumers make informed decisions about dental products

For more than 125 years, the American Dental Association (ADA) has been evaluating dental products for safety and effectiveness. The ADA Seal of Acceptance, which is a registered certification mark, is awarded after a product is tested and meets ADA guidelines and standards. The Pennsylvania Dental Association encourages you to shop wisely and purchase dental care products with the ADA Seal.

NY election may offer view of voters' take on GOP Medicare plan

Just as this New York special congressional election approaches, news outlets analyze how public opinion is breaking in regard to the plan, as included in the budget advanced by Rep. Paul Ryan, R-Wis. Other elected officials are also offering their own responses to the approach.

Opinions: Don't slow fight against HIV, TB, malaria; U.S. focus on women, girls

In a BusinessDay opinion piece, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria Michel Kazatchkine reflects on the organization's progress and impact on global health outcomes since its creation in 2002, as detailed in the organizations' 2010 annual report. Kazatchkine writes, 2010 "will be a decisive year; the world will be reviewing progress on the millennium goals. But this is also the year of the fund's replenishment. The results of that will decide where the world will be in 2015 with regard to the millennium goals."

SNM's Nanomedicine and Molecular Imaging Summit examines the use of nanoparticles

SNM's Nanomedicine and Molecular Imaging Summit wrapped up today in Albuquerque, N.M., with in-depth discussion-and a high sense of energy looking ahead.

Prolong Pharmaceuticals' SANGUINATE granted FDA Orphan Drug Designation for SCD treatment

Prolong Pharmaceuticals, LLC, a biopharmaceutical company dedicated to developing products for the treatment of anemias, cancers and their debilitating comorbidities, announced today that the U.S. Food and Drug Administration has granted Orphan Drug Designation for its flagship product SANGUINATE for the treatment of Sickle Cell Disease (SCD).

Read more Medical News

› Verified 1 days ago